Altamira Therapeutics Announces Publication of Preclinical Data Showing Successful Treatment of Abdominal Aortic Aneurysm with SOD2 mRNA Delivered by SemaPhore Nanoparticles
Stock Information for Altamira Therapeutics Ltd.
Loading
Please wait while we load your information from QuoteMedia.